Skip to content
OpenCapital
Get started

Boston Scientific BSX Europe, Middle East and Africa — Net Sales

Other geography segments

Asia-Pacific
$803M+14.6%
Latin America and Canada
$185M+19.4%

Similar metrics at other companies

CONMED logo
CNMDEurope, Middle East & Africa — Net Sales
$69.14M+8.6%
Stryker logo
SYKEurope, Middle East, Africa — Net Sales
$795.25M+9.8%
10x Genomics, Inc. logo
TXGEurope, Middle East and Africa — Revenue
$36.85M+15.5%
DENTSPLY SIRONA logo
XRAYEMEA — Net Sales
$435M+6.9%
TFX
TFXEMEA — Net revenues
$146.68M+77.5%
Vertiv Holdings Co logo
VRTEurope, Middle East, & Africa — Net Sales
$494.9M-6.3%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$65.7B-56.2%
P/E18.5×-55.6×
P/S3.2×-5.4×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's europe, middle east and africa — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's europe, middle east and africa — net sales?
Boston Scientific (BSX) reported europe, middle east and africa — net sales of $932M in Q1 2026.
How has Boston Scientific's europe, middle east and africa — net sales changed year-over-year?
Boston Scientific's europe, middle east and africa — net sales increased by 10.2% year-over-year, from $846M to $932M.
What is the long-term trend for Boston Scientific's europe, middle east and africa — net sales?
Over 4 years (2021 to 2025), Boston Scientific's europe, middle east and africa — net sales has grown at a 8.2% compound annual growth rate (CAGR), from $2.52B to $3.45B.
What does europe, middle east and africa — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and related services within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration, demand for interventional medical technologies, and the effectiveness of regional commercial operations. This figure is a critical indicator of the firm's international footprint and its ability to navigate diverse regulatory and healthcare reimbursement environments.